Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial [Phase 3]
A Phase 3 bridging trial to evaluate the immunogenicity and safety of a live varicella vaccine in healthy Vietnamese children aged 1–12 year…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years [Phase 3]
Phase 3 trial update for SkyVaricella (NBP608) in healthy children shows lower potencies. The study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program
A completed clinical trial assessing seroprevalence and vaccination rates for hepatitis B and varicella in medical students under an immuniz…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age [Phase 2]
Phase 2 trial comparing immune response and safety of a combined measles, mumps, rubella, and varicella vaccine against a marketed MMRV vacc…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years [Phase 1]
A Phase 1 trial to evaluate the EuHZV vaccine in healthy adults aged 50 to 69 years is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion) [Phase 4]
A Phase 4 study completed evaluating simultaneous administration of varicella attenuated live vaccine and trivalent inactivated influenza va…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age [Phase 2]
Phase 2 trial evaluating immune response and safety of multiple doses of an investigational varicella (chickenpox) vaccine compared with a m…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: ACTIVATE in Public Housing [NA]
A completed clinical trial (ACTIVATE) in public housing studying interventions related to pneumonia, influenza, varicella, meningitis, COVID…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines [Phase 3]
A Phase 3 study evaluating the immunogenicity and safety of a live varicella vaccine in healthy children aged 12-15 months in the Philippine…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: An Immunity Persistence Study of Live Attenuated Varicella Vaccine [Phase 4]
A Phase 4 immunity persistence study of a live attenuated varicella vaccine is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of a live attenuated varicella vaccine in children aged 1-12 years has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years [Phase 3]
Phase III trial evaluating the immunogenicity and safety of a lyophilized live-attenuated varicella vaccine in healthy subjects aged 13 to 5…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy [Phase 1]
Phase 1 clinical trial evaluating safety, pharmacokinetics and pharmacodynamics of TNM005 in healthy adults; Varicella is the listed conditi…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old [Phase 3]
Phase 3 trial update evaluating safety and immunogenicity of a live attenuated varicella vaccine in healthy individuals aged 13 and older.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old [Phase 3]
A Phase 3 trial update assessing safety and immunogenicity of a live attenuated varicella vaccine in healthy individuals aged 13 and older h…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines [Phase 4]
Phase 4 trial updating immunogenicity and safety of an inactivated SARS-CoV-2 vaccine when coadministered with two attenuated vaccines, focu…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine [Phase 3]
A Phase III clinical trial evaluating the efficacy and safety of a live attenuated varicella vaccine for varicella, currently active but not…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age [Phase 3]
A Phase 3 clinical trial update evaluating lot-to-lot consistency of a live attenuated varicella vaccine in healthy children aged 1–12 years…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province [Phase 4]
Phase 4 trial update on a live attenuated varicella vaccine assessing protective effect, safety, and immunogenicity in Anhui Province.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus [Phase 4]
Phase 4 trial update evaluating immunogenicity, safety, and protective effect of a live attenuated varicella vaccine with antibody level and…
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine [Phase 4]
Phase 4 trial update on combined immunization with live attenuated varicella vaccine and inactivated hepatitis A vaccine; study completed.
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization [Phase 3]
Phase 3 open-label trial assessing immunity persistence after primary varicella vaccination and safety/immunogenicity after booster vaccinat…
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011) [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of concomitant MMR rHA and VARIVAX given intramuscularly versus subcutaneously.